Literature DB >> 14624331

Attenuation of ethanol self-administration and of conditioned reinstatement of alcohol-seeking behaviour by the antiopioid peptide nociceptin/orphanin FQ in alcohol-preferring rats.

Roberto Ciccocioppo1, Daina Economidou, Amalia Fedeli, Stefania Angeletti, Friedbert Weiss, Markus Heilig, Maurizio Massi.   

Abstract

RATIONALE: Nociceptin/orphanin FQ (N/OFQ), the endogenous ligand of the opioid-like orphan receptor NOP, was shown to reduce home-cage ethanol consumption, ethanol-induced conditioned place preference and stress-induced reinstatement of alcohol-seeking behaviour.
OBJECTIVES: The present study, using genetically selected Marchigian Sardinian alcohol-preferring (msP) rats, was designed to evaluate the effect of this opioid peptide on 10% ethanol and 10% sucrose self-administration, under a fixed-ratio 1 (FR 1) or a progressive-ratio (PR) schedule of reinforcement. Furthermore, using an experimental model of relapse in which rats were trained to lever press for ethanol in the presence of the discriminative stimulus of an orange odour (S(+)) and a 1-s cue light (CS(+)) or for water in the presence of anise odour (S(-)) and 1-s white noise (CS(-)), the effect of N/oFQ on cue-induced reinstatement of extinguished ethanol responding was investigated.
RESULTS: Sub-chronic (6 days) intracerebroventricular (i.c.v.) injection of 0.5 microg or 1.0 microg N/OFQ per rat significantly reduced alcohol self-administration under both the FR 1 and PR schedules of reinforcement. Conversely, i.c.v. administration of 0.5, 1.0 or 4.0 microg of the peptide per rat did not affect sucrose self-administration. In addition, i.c.v. N/OFQ (1.0-2.0 microg per rat) significantly inhibited the reinstatement of extinguished ethanol responding under an S(+)/CS(+) condition, whereas lever pressing under S(-)/CS(-) was not altered.
CONCLUSIONS: The present study demonstrates that the reinforcing effects of ethanol are markedly blunted by activation of the opioidergic N/OFQ receptor system. Moreover, the data provide evidence of the efficacy of N/OFQ to prevent reinstatement of ethanol-seeking behaviour elicited by environmental conditioned stimuli.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14624331      PMCID: PMC3035816          DOI: 10.1007/s00213-003-1645-1

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  59 in total

1.  Pharmacological characterization of the nociceptin receptor which mediates reduction of alcohol drinking in rats.

Authors:  Roberto Ciccocioppo; Carlo Polidori; Lorena Antonelli; Severo Salvadori; Remo Guerrini; Maurizio Massi
Journal:  Peptides       Date:  2002-01       Impact factor: 3.750

Review 2.  Neuroscience of addiction.

Authors:  G F Koob; P P Sanna; F E Bloom
Journal:  Neuron       Date:  1998-09       Impact factor: 17.173

3.  Conditioning factors in drug abuse: can they explain compulsion?

Authors:  C P O'Brien; A R Childress; R Ehrman; S J Robbins
Journal:  J Psychopharmacol       Date:  1998       Impact factor: 4.153

4.  Intracerebroventricular orphanin FQ/nociceptin suppresses dopamine release in the nucleus accumbens of anaesthetized rats.

Authors:  N P Murphy; H T Ly; N T Maidment
Journal:  Neuroscience       Date:  1996-11       Impact factor: 3.590

5.  Alcohol-preferring rats: genetic sensitivity to alcohol-induced stimulation of dopamine metabolism.

Authors:  F Fadda; E Mosca; G Colombo; G L Gessa
Journal:  Physiol Behav       Date:  1990-04

6.  Alcohol-predictive cues enhance tolerance to and precipitate "craving" for alcohol in social drinkers.

Authors:  C G McCusker; K Brown
Journal:  J Stud Alcohol       Date:  1990-11

7.  The peptide orphanin FQ inhibits beta-endorphin neurons and neurosecretory cells in the hypothalamic arcuate nucleus by activating an inwardly-rectifying K+ conductance.

Authors:  E J Wagner; O K Rønnekleiv; D K Grandy; M J Kelly
Journal:  Neuroendocrinology       Date:  1998-02       Impact factor: 4.914

8.  Effect of selective blockade of mu(1) or delta opioid receptors on reinstatement of alcohol-seeking behavior by drug-associated stimuli in rats.

Authors:  Roberto Ciccocioppo; Rémi Martin-Fardon; Friedbert Weiss
Journal:  Neuropsychopharmacology       Date:  2002-09       Impact factor: 7.853

Review 9.  Orphanin FQ/nociceptin: a role in pain and analgesia, but so much more.

Authors:  T Darland; M M Heinricher; D K Grandy
Journal:  Trends Neurosci       Date:  1998-05       Impact factor: 13.837

10.  Ventral mesencephalic delta opioid receptors are involved in modulation of basal mesolimbic dopamine neurotransmission: an anatomical localization study.

Authors:  D P Devine; P Leone; W A Carlezon; R A Wise
Journal:  Brain Res       Date:  1993-09-17       Impact factor: 3.252

View more
  72 in total

1.  Effects of A₂A adenosine receptor blockade or stimulation on alcohol intake in alcohol-preferring rats.

Authors:  Maria Vittoria Micioni Di Bonaventura; Carlo Cifani; Catia Lambertucci; Rosaria Volpini; Gloria Cristalli; Rino Froldi; Maurizio Massi
Journal:  Psychopharmacology (Berl)       Date:  2011-08-11       Impact factor: 4.530

2.  Factors mediating alcohol craving and relapse: stress, compulsivity, and genetics.

Authors:  Zachary A Rodd; Kristin K Anstrom; Darin J Knapp; Ildiko Racz; Andreas Zimmer; Salvatore Serra; Richard L Bell; Donald J Woodward; George R Breese; Giancarlo Colombo
Journal:  Alcohol Clin Exp Res       Date:  2005-07       Impact factor: 3.455

3.  Nociceptin Receptors in Alcohol Use Disorders: A Positron Emission Tomography Study Using [11C]NOP-1A.

Authors:  Rajesh Narendran; Roberto Ciccocioppo; Brian Lopresti; Jennifer Paris; Michael L Himes; N Scott Mason
Journal:  Biol Psychiatry       Date:  2017-05-31       Impact factor: 13.382

Review 4.  Influence of stress associated with chronic alcohol exposure on drinking.

Authors:  Howard C Becker
Journal:  Neuropharmacology       Date:  2017-04-19       Impact factor: 5.250

5.  Pharmacological profile of the NOP agonist and cough suppressing agent SCH 486757 (8-[Bis(2-Chlorophenyl)Methyl]-3-(2-Pyrimidinyl)-8-Azabicyclo[3.2.1]Octan-3-Ol) in preclinical models.

Authors:  Robbie L McLeod; Deen B Tulshian; Donald C Bolser; Geoffrey B Varty; Marco Baptista; Xiomara Fernandez; Leonard E Parra; Jennifer C Zimmer; Christine H Erickson; Ginny D Ho; Yanlin Jia; Fay W Ng; Walter Korfmacher; Xiaoying Xu; John Veals; April Smith-Torhan; Samuel Wainhaus; Ahmad B Fawzi; Theodore M Austin; Margaret van Heek; John A Hey
Journal:  Eur J Pharmacol       Date:  2009-12-16       Impact factor: 4.432

6.  Comparison of the antinociceptive and antirewarding profiles of novel bifunctional nociceptin receptor/mu-opioid receptor ligands: implications for therapeutic applications.

Authors:  Lawrence Toll; Taline V Khroyan; Willma E Polgar; Faming Jiang; Cris Olsen; Nurulain T Zaveri
Journal:  J Pharmacol Exp Ther       Date:  2009-09-22       Impact factor: 4.030

7.  Caloric restriction increases the sensitivity to the hyperphagic effect of nociceptin/orphanin FQ limiting its ability to reduce binge eating in female rats.

Authors:  Maria Vittoria Micioni Di Bonaventura; Massimo Ubaldi; Sonia Liberati; Roberto Ciccocioppo; Maurizio Massi; Carlo Cifani
Journal:  Psychopharmacology (Berl)       Date:  2013-03-02       Impact factor: 4.530

8.  MT-7716, a potent NOP receptor agonist, preferentially reduces ethanol seeking and reinforcement in post-dependent rats.

Authors:  Giordano de Guglielmo; Rémi Martin-Fardon; Koji Teshima; Roberto Ciccocioppo; Friedbert Weiss
Journal:  Addict Biol       Date:  2014-06-16       Impact factor: 4.280

9.  Genetic Deletion of the Nociceptin/Orphanin FQ Receptor in the Rat Confers Resilience to the Development of Drug Addiction.

Authors:  Marsida Kallupi; Giulia Scuppa; Giordano de Guglielmo; Girolamo Calò; Friedbert Weiss; Michael A Statnick; Linda M Rorick-Kehn; Roberto Ciccocioppo
Journal:  Neuropsychopharmacology       Date:  2016-08-26       Impact factor: 7.853

Review 10.  Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems.

Authors:  Lawrence Toll; Michael R Bruchas; Girolamo Calo'; Brian M Cox; Nurulain T Zaveri
Journal:  Pharmacol Rev       Date:  2016-03-08       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.